All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation or HealthTree for Multiple Myeloma.
An expert panel hosted by
Sequencing immune-based therapies in B-cell malignancies
with Ulric Jäger, Sagar Lonial, and Krina Patel
Saturday, June 15 | 18:00-19:30 CEST
Register nowThis independent education activity is sponsored by Bristol Myers Squibb. All content is developed independently by the faculty. Funders are allowed no direct influence on the content of this activity.
The Multiple Myeloma Hub website uses a third-party service provided by Google that dynamically translates web content. Translations are machine generated, so may not be an exact or complete translation, and the Multiple Myeloma Hub cannot guarantee the accuracy of translated content. The Multiple Myeloma Hub and its employees will not be liable for any direct, indirect, or consequential damages (even if foreseeable) resulting from use of the Google Translate feature. For further support with Google Translate, visit Google Translate Help.
To help navigate the exciting content being presented at the 65th American Society of Hematology (ASH) Annual Meeting and Exposition, the Multiple Myeloma Hub Steering Committee have provided their recommendations for the top abstracts to look out for in multiple myeloma and other plasma cell dyscrasias.
4 |
Francesca Gay |
|
207 |
Cyrille Touzeau |
|
208 |
Niels W.C.J. van de Donk |
|
209 |
Maria-Victoria Mateos |
|
339 |
Minimally invasive assessment of measurable residual disease (MRD) in multiple myeloma (MM) |
Carmen Gonzalez |
340 |
Tadeusz Kubicki |
|
342 |
Febe Smits |
|
533 |
Cristina Perez |
|
647 |
Nisha S. Joseph |
|
1022 |
Juan Du |
|
4762 |
Jeffrey A. Zonder |
|
LBA-1 |
Pieter Sonneveld |
91 |
Danai Dima |
|
219 |
Susan Bal |
|
338 |
Nizar J. Bahlis |
|
761 |
Chunrui Li |
|
783 |
Gordon Cook |
|
1009 |
Wee-Joo Chng |
|
1010 |
Ajai Chari |
|
1011 |
Hang Quach |
|
1013 |
Paul G. Richardson |
|
1014 |
Jeffrey V. Matous |
|
1021 |
Jens Hilengrass |
|
1027 |
Surbhi Sidana |
|
1028 |
Paula Rodríguez Otero |
|
3377 |
Andrzej J. Jakubowiak |
|
3499 |
Shonali Midha |
210 |
Ola Landgren |
|
530 |
Jon Thorir Oskarsson |
|
539 |
Efstathios Kastritis |
|
542 |
Hira Mian |
|
645 |
Noemi Puig |
|
754 |
Exploiting the gut microbiota to boost immunotherapy and switch the trajectory of multiple myeloma |
Laura Lucia Cogrossi |
In addition to the top abstracts selected by our steering committee, the Multiple Myeloma Hub would like to highlight some key region-specific abstracts in the field of multiple myeloma and plasma cell dyscrasias.
3346 |
Renal Failure in Patients with Newly Diagnosed Multiple Myeloma Eligible for Autologous Stem Cell Transplant in LATAM - on behalf of Gelamm |
Humberto Martinez-Cordero |
3352 |
Eloisa Riva |
3325 |
Kenneth J C Lim |
|
2019 |
Slavisa Ninkovic |
|
2225 |
Sumeet Mirgh |
|
4845 |
Chengcheng Fu |
1981 |
Eirini Katodritou |
|
2020 |
Agoston Gyula Szabo |
|
4696 |
Cecilie Hveding Blimark |
|
4729 |
Kari Lenita Falck Moore |
|
4734 |
Efstathios Kastritis |
|
4973 |
Autologous stem cell transplantation for multiple myeloma in Algeria |
Malek Benakli |
Subscribe to get the best content related to multiple myeloma delivered to your inbox